Polymorphisms of tumor necrosis factor-α and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy

Japanese Heart Journal

Volumn 41, Issue 2, 2000, Pages 183-191

  Ito, Masahiro ^a   Takahashi, Hidenobu ^a   Fuse, Koichi ^a   Hirono, Satoru ^a   Washizuka, Takashi ^a   Kato, Kiminori ^a   Yamazaki, Fusako ^b   Inano, Koichi ^b   Furukawa, Tatsuo ^b   Komada, Makoto ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Cardiomyopathy; Interleukin 10; Polymorphism; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; JAPAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 18744426716     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.183     Document Type: Article

References (21)

1. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577-95.
2. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997; 95: 778-81.
3. Levine B, Kaiman J, Mayer L, Fillit HM, Packer M, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 223: 236-41.
4. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.
5. Torre-amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
6. Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 1996; 75: 287-90.
7. Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-82.
8. Wilson AG, Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992; 1: 353.
9. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effect of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
10. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
11. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1994; 12: 127-33.
12. Kubota T, McNamara DM, Wang JJ, et al. Effect of tumor necrosis factor gene polymorpohism on patients with congestive heart failure. Circulation 1998; 97: 2499-501.
13. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization / Internal Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathy. Circulation 1996; 93: 841-2.
14. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis (TNF)-α gene in Japanese. Tissue Antigens 1998; 51: 605-12.
15. Wynne J, Braunwald E. The cardiomyopathies and myocarditis. In: Braunwald E, editor. Heart Disease, 5th edn. Philadelphia: WB Saunders, 1997; 1404-63.
16. Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 1997; 81: 627-35.
17. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996; 347: 1151-5.
18. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 1994; 90: 12-16.
19. Van der Poll T, Jansen J, Levi M, Ten Cate H, Ten Cate JW, Van Deventer SJ. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994; 180: 1985-8.
20. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
21. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for the tumor necrosis factors α and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83: 8699-702.